Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -20.73% | -34.36% | -46.73% | -3.36% | 84.55% |
| Total Revenue | -20.73% | -34.36% | -46.73% | -3.36% | 84.55% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -20.73% | -34.36% | -46.73% | -3.36% | 84.55% |
| SG&A Expenses | 14.84% | 12.02% | 10.56% | 7.40% | 4.07% |
| Depreciation & Amortization | 3.16% | 0.85% | -0.07% | -1.42% | -2.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.72% | 7.87% | -11.59% | -8.65% | -5.14% |
| Operating Income | -80.96% | -42.27% | -14.89% | 11.42% | 34.07% |
| Income Before Tax | -81.83% | -40.80% | -12.08% | 13.10% | 34.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -81.83% | -40.80% | -12.08% | 13.10% | 34.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.83% | -40.80% | -12.08% | 13.10% | 34.84% |
| EBIT | -80.96% | -42.27% | -14.89% | 11.42% | 34.07% |
| EBITDA | -83.52% | -43.45% | -15.27% | 11.66% | 34.76% |
| EPS Basic | -72.73% | -12.90% | 20.00% | 38.64% | 54.17% |
| Normalized Basic EPS | -57.14% | -10.53% | 16.67% | 37.04% | 53.33% |
| EPS Diluted | -72.73% | -12.90% | 20.00% | 38.64% | 54.17% |
| Normalized Diluted EPS | -57.14% | -10.53% | 16.67% | 37.04% | 53.33% |
| Average Basic Shares Outstanding | 19.05% | 27.24% | 37.04% | 36.10% | 35.04% |
| Average Diluted Shares Outstanding | 19.05% | 27.24% | 37.04% | 36.10% | 35.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |